Value sales of analgesics is expected to remain unchanged in 2021. While there was a huge surge in analgesics sales in 2020, as it was used to alleviate symptoms of COVID-19, now that fears around of the virus have abated somewhat, there is expected to be less demand for analgesics.
GSK Consumer Healthcare took the lead in analgesics in 2019 and has maintained its top place. Backed by global player GlaxoSmithKline Plc, GSK Consumer Healthcare holds the top two brands in analgesics in the Netherlands, namely Voltaren and Panadol.
Within systemic analgesics, both diclofenac and ibuprofen are under pressure and the long-term outlook is also bleak. There was a minor spike in sales of diclofenac during the first wave of COVID-19, as some consumers decided to stock up as they were unsure about availability.
Analgesics will register moderate constant value growth over the forecast period. However, the pandemic will have a lasting impact and could dampen value sales somewhat.
Topical analgesics are expected to register the highest value growth in 2021 and this will also drive value growth over the forecast period. A recent change in legislation allows topical analgesics manufacturers to increase the dose of diclofenac and had led to increased value sales and will continue to do so over the forecast period.
The long-term burden of healthcare in the Netherlands is worrying, with escalating costs on the horizon. There is a debate about what measures are appropriate to limit increased healthcare costs, which will be under increased pressure in the near future, due to an ageing population.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Netherlands with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Netherlands, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!